Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc MMIRF


Primary Symbol: V.MIR

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

MedMira Inc > medmira financial year 2022 over 1/2 finished
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Post by goldyhawkon Feb 14, 2022 6:21pm
256 Views
Post# 34428139

medmira financial year 2022 over 1/2 finished

medmira financial year 2022 over 1/2 finished
MEDMIRA  IS ALL OVER THE PLACE 

WHAT'S  NEXT ??    SALES PLEASE 


Tests for syphilis and AIDS are on the way 

----four covid tests 
vyra  covid 19
 
vyra  cov2 flu
 
reveal covid  19  plus
 
reveal covid 19  nab-y
 
 

MedMira Inc. Trademarks
REVEALCOVID-19
 

REVEALCOVID-19

Filed: October 7, 2020
Medical diagnostic test kits in the form of test cartridges and solutions for detecting the presence of antigens and antibodies…
Owned by: MedMira Inc.
Serial Number: 90240954

 
VYRA
 

VYRA

Filed: December 23, 2020
Medical test kits for identifying viruses
Owned by: MedMira Inc.
Serial Number: 90407022

 
PYRA
 

PYRA

Filed: December 23, 2020
Medical test kits for identifying parasites
Owned by: MedMira Inc.
Serial Number: 90407030

 
BYRA
 

BYRA

Filed: December 23, 2020
Medical test kits for identifying bacteria
Owned by: MedMira Inc.
Serial Number: 90407
042   
and so on 
and on

and on and on


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities